Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Retrophin, Inc. (RTRX)
Sector: Healthcare; Industry: Biotechnology

Retrophin, Inc., a biopharmaceutical company, focuses on the identification, development, and commercialization of therapies for the treatment of rare diseases. The company's product candidates also consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-18 ROTE WILLIAM E. Senior Vice President, R&D Sell 2,500 $28.01 $70,025 No
2021-02-08 Rosenberg Noah L. Chief Medical Officer Sell 2,250 $31.50 $70,864 No
2021-02-08 Heerma Peter Chief Commercial Officer Sell 2,250 $31.50 $70,864 No
2021-02-08 ROTE WILLIAM E. Senior Vice President, R&D Sell 4,500 $31.50 $141,728 No
2021-02-08 REED ELIZABETH E SVP, GC & Corporate Secretary Sell 4,500 $31.50 $141,728 No
2021-02-08 Clague Laura Chief Financial Officer Sell 4,500 $31.50 $141,728 No
2021-02-08 Dube Eric M Chief Executive Officer Sell 9,626 $31.50 $303,171 No
2021-02-03 Heerma Peter Chief Commercial Officer Sell 1,126 $29.83 $33,589 No
2021-02-03 Rosenberg Noah L. Chief Medical Officer Sell 1,813 $28.91 $52,414 No
2021-02-03 ROTE WILLIAM E. Senior Vice President, R&D Sell 3,625 $28.91 $104,799 No
2021-02-03 REED ELIZABETH E SVP, GC & Corporate Secretary Sell 3,175 $28.91 $91,789 No
2021-02-03 Clague Laura Chief Financial Officer Sell 3,625 $28.91 $104,799 No
2021-02-03 Dube Eric M Chief Executive Officer Sell 2,406 $28.91 $69,557 No
2021-02-02 Rosenberg Noah L. Chief Medical Officer Sell 1,813 $30.75 $55,750 No
2021-02-02 ROTE WILLIAM E. Senior Vice President, R&D Sell 3,625 $30.75 $111,469 No
2021-02-02 REED ELIZABETH E SVP, GC & Corporate Secretary Sell 3,175 $30.75 $97,631 No
2021-02-02 Dube Eric M Chief Executive Officer Sell 8,734 $29.91 $261,267 No
2021-02-02 Clague Laura Chief Financial Officer Sell 3,625 $30.75 $111,469 No
2021-02-02 ASELAGE STEVE Director Sell 25,000 $30.75 $768,750 Yes
2021-01-06 REED ELIZABETH E SVP, GC & Corporate Secretary Sell 1,376 $26.83 $36,918 No
2021-01-06 Dube Eric M Chief Executive Officer Sell 6,876 $26.83 $184,483 No
2020-12-15 ASELAGE STEVE Director Sell 5,549 $26.02 $144,385 No
2020-12-02 ASELAGE STEVE Director Sell 7,891 $23.43 $184,849 No
2020-11-25 Clague Laura Chief Financial Officer Sell 7,500 $23.29 $174,675 No
2020-11-16 ROTE WILLIAM E. Senior Vice President, R&D Sell 2,500 $23.96 $59,900 No
2020-11-16 Clague Laura Chief Financial Officer Sell 7,500 $23.98 $179,812 No
2020-11-16 REED ELIZABETH E SVP, GC & Corporate Secretary Sell 2,500 $23.98 $59,950 No
2020-11-13 REED ELIZABETH E SVP, GC & Corporate Secretary Sell 2,500 $23.62 $59,046 No
2020-11-13 ROTE WILLIAM E. Senior Vice President, R&D Sell 2,500 $23.62 $59,056 No
2020-11-13 Clague Laura Chief Financial Officer Sell 7,500 $23.61 $177,071 No

Insider Smart

SERVICE CORP INTERNATIONAL (SCI) - WALTRIP W BLAIR, Director of $SCI made a buy at 34.65, was he convinced the bottom of the box is a strong support? Well, seems he is not wrong.

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?